Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Revenue (2020 - 2025)

Historic Revenue for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q2 2025 value amounting to $1000.0.

  • Barinthus Biotherapeutics' Revenue changed N/A to $1000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $317000.0, marking a year-over-year decrease of 9788.23%. This contributed to the annual value of $15.0 million for FY2024, which is 176645.89% up from last year.
  • Barinthus Biotherapeutics' Revenue amounted to $1000.0 in Q2 2025.
  • Barinthus Biotherapeutics' 5-year Revenue high stood at $17.1 million for Q2 2022, and its period low was -$1000.0 during Q4 2021.
  • Moreover, its 5-year median value for Revenue was $334000.0 (2023), whereas its average is $4.7 million.
  • In the last 5 years, Barinthus Biotherapeutics' Revenue plummeted by 10028.25% in 2021 and then soared by 64580000.0% in 2022.
  • Over the past 5 years, Barinthus Biotherapeutics' Revenue (Quarter) stood at -$1000.0 in 2021, then soared by 645800.0% to $6.5 million in 2022, then tumbled by 94.83% to $334000.0 in 2023, then surged by 4381.74% to $15.0 million in 2024, then crashed by 99.99% to $1000.0 in 2025.
  • Its Revenue was $1000.0 in Q2 2025, compared to $316000.0 in Q1 2025 and $15.0 million in Q3 2024.